TROP2 CAREngineered Cord Blood-Derived NK Cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for TROP2 CAREngineered Cord Blood-Derived NK Cells, covering 2026-01-30 to 2026-01-30. Get the full timeline:
Most recent: Clinical Trial Update: Phase 1/2 Study TROP2 CAREngineered Cord Blood-Derived NK Cells + Belzutifan In Pancreatic Cancer [Phase 1, Phase 2]